1. 5PSQ-097 Toxicity associated with gene polymorphisms in patients with colorectal cancer, treated with fluoropyrimidines and analogues, irinotecan and platinum coordination complexes. (2nd March 2018) Authors: Cricchio, G Lo; Saibene, G; Ruffino, E; Laganà, G; Costanza, C Della; Pietrantonio, F; Falvella, S; Nichetti, F; Celotti, FM; Ladisa, V Journal: European journal of hospital pharmacy Issue: Volume 25(2018)Supplement 1 Page Start: A209 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 5PSQ-101 Oncolytic viruses risk and control assessment: talimogene laherparepvec experience. (2nd March 2018) Authors: Costanza, C Della; Saibene, G; Laganà, G; Ruffino, E; Antonacci, G; Langella, R; Mauro, C Di; Galassi, M; Re, B; Ladisa, V Journal: European journal of hospital pharmacy Issue: Volume 25(2018)Supplement 1 Page Start: A211 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Assessment of the ITER electron cyclotron upper launcher capabilities in view of an optimized design. (15th April 2015) Authors: Figini, L; Farina, D; Henderson, M; Mariani, A; Poli, E; Saibene, G Journal: Plasma physics and controlled fusion Issue: Volume 57:Number 5(2015:May) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Assessment of the ITER electron cyclotron upper launcher capabilities in view of an optimized design. (May 2015) Authors: Figini, L; Farina, D; Henderson, M; Mariani, A; Poli, E; Saibene, G Journal: Plasma physics and controlled fusion Issue: Volume 57:Number 5(2015:May) Page Start: 193 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. CP-004 Analysis of treatment with pembrolizumab in patients with metastatic melanoma in the expanded access programme (EAP). (14th February 2016) Authors: Togliardi, E; Lanzo, G; Antonacci, G; Langella, R; Costanza, C Della; Saibene, G Journal: European journal of hospital pharmacy Issue: Volume 23(2016)Supplement 1 Page Start: A2 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. CP-196 Axitinib induced blood pressure elevation associated with a longer progression free survival: A retrospective analysis. (14th February 2016) Authors: Langella, R; Festinese, F; Nurra, S; Lanzo, G; Togliardi, E; Della Costanza, C; Antonacci, G; Di Mauro, C; Mazzer, M; Saibene, G Journal: European journal of hospital pharmacy Issue: Volume 23(2016)Supplement 1 Page Start: A87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. CPC-035 Compassionate Use: Pharmacovigilance. (12th March 2013) Authors: Saibene, G; Togliardi, E; Brera, F; Festinese, F; Mazzer, M; Antonacci, G; Di Mauro, V Journal: European journal of hospital pharmacy Issue: Volume 20(2013)Supplement 1 Page Start: A178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. CPC-153 Ward Pharmacist: Managing Interactions in the Department of Haematology and Bone Marrow Transplantation. (12th March 2013) Authors: Saibene, G; Brera, F; Togliardi, E; Antonacci, G; Festinese, F; Mazzer, M; Di Mauro, V Journal: European journal of hospital pharmacy Issue: Volume 20(2013)Supplement 1 Page Start: A220 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. DI-065 Safety of dabrafenib: Analysis of data from italian spontaneous reporting database. (14th February 2016) Authors: Langella, R; Festinese, F; Re, B; Lanzo, G; Togliardi, E; Nurra, S; Antonacci, G; Di Mauro, C; Mazzer, M; Saibene, G Journal: European journal of hospital pharmacy Issue: Volume 23(2016)Supplement 1 Page Start: A146 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. GM-019 Use of imatinib in GIST and CML: comparison of expenditure between National Cancer Institute of Milan and national expenditure. (24th February 2014) Authors: Festinese, F; Togliardi, E; Brera, F; Di Mauro, C; Lanzo, G; Bifano, F; Saibene, G Journal: European journal of hospital pharmacy Issue: Volume 21(2014)Supplement 1 Page Start: A121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗